U.S. markets open in 7 hours 21 minutes
  • S&P Futures

    4,322.25
    +8.75 (+0.20%)
     
  • Dow Futures

    33,833.00
    +42.00 (+0.12%)
     
  • Nasdaq Futures

    14,769.25
    +30.25 (+0.21%)
     
  • Russell 2000 Futures

    1,796.90
    +3.90 (+0.22%)
     
  • Crude Oil

    94.54
    +0.86 (+0.92%)
     
  • Gold

    1,894.00
    +3.10 (+0.16%)
     
  • Silver

    22.75
    +0.03 (+0.11%)
     
  • EUR/USD

    1.0511
    +0.0002 (+0.02%)
     
  • 10-Yr Bond

    4.6260
    0.0000 (0.00%)
     
  • Vix

    18.22
    -0.72 (-3.80%)
     
  • GBP/USD

    1.2141
    +0.0001 (+0.01%)
     
  • USD/JPY

    149.3730
    -0.1870 (-0.13%)
     
  • Bitcoin USD

    26,414.47
    +163.57 (+0.62%)
     
  • CMC Crypto 200

    566.67
    +4.02 (+0.72%)
     
  • FTSE 100

    7,593.22
    -32.50 (-0.43%)
     
  • Nikkei 225

    31,936.46
    -435.44 (-1.35%)
     

Market check: Stocks mixed, crude oil slides, pharmaceuticals swing on earnings

Yahoo Finance's Ines Ferre provides an overview of the stock and oil markets today.

Video Transcript

BRIAN SOZZI: Ines.

INES FERRE: And Brian, let's take a look at oil right now because WTI is sliding down more than 2%, under $90 a barrel right now. We've got Brent crude that is also lower. Let's take a look right now at the sector action. As we're looking at mixed markets, we are seeing financials and materials that are in the green, but we've got energy that is losing the most right now, as well as a real estate.

Looking at the Rx, the healthcare players today, quite a bit of action going on here. You've got Pfizer that's down more than 5% after its fourth quarter sales missed estimates, its revenue forecast for the full year of 2022 also missing expectations. Then you've got BioNTech that is down, BioNTech being Pfizer's partner working on clearing that under 5 vaccine down more than 9%. And Moderna is also lower right now.

We are looking at shares of Amgen up more than 4% after announcing a share buyback plan. Its revenue guidance came in short of expectations the stock, though, still really holding up well during today's market action. And then looking at the NASDAQ 100, I do want to mention that we are seeing, of course, Peloton being the best performer right now, being the outperformer of more than 12%. We've spoken quite a bit about Peloton today.

But I also want to mention Fiserv down 5%. The fintech company's revenue growth outlook for 2022 came in lower than 2021, that's why you're seeing pressure on the stock.